Bruker Launches the New BEAM, a Dedicated Single-Point FT-NIR Spectrometer Designed for In-Process Control
ETTLINGEN, Germany – February 29th, 2024 – Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new BEAM – the first dedicated single-point spectrometer unleashing the full power of FT-NIR spectroscopy, taking in-process control for solid samples to the next level.
Unlike common single-point analyzers based on filter or diode-array technology, the BEAM uses FT-NIR technology based on Bruker’s RockSolidTM interferometer to ensure it can perform the same applications with the same precision, accuracy, and long-term stability you would expect from a high-end lab-based system.
Despite its advanced technology, the BEAM is compact and lightweight, making it easy to install it with the dedicated mounting brackets or Tri-clamp flanges in any setting and orientation at pipelines, and chutes or over conveyor belts. With its dual-lamp operation mode, uninterrupted system availability is ensured, and the service intervals are extended for optimized productivity and efficiency.
Designed for on-the-spot quality control, the BEAM is IP65 protected, making it suitable for use in harsh environments. With future-proof connectivity, the BEAM is ready to integrate with your existing process control systems and adapt to future technological advancements.
Dr. Holger Lutz, Business Unit Manager Chemistry, Pharma & Process of Bruker Optics stated: "The new BEAM is a milestone in the way that process analysis of solid samples will be carried out in the future. The BEAM will master applications that were out of reach for most conventional single point analyzers by utilizing the full NIR spectral range that is only available in FT-NIR systems. Its high resolution will give you the best accuracy and repeatability – time and time again."
Dr. Jörg-Peter Conzen, Vice President Applied Spectroscopy of Bruker Optics added: "The new BEAM is an excellent addition to our current FT-NIR spectrometer portfolio. As a business, we constantly strive to meet and exceed our customers' expectations. We place a high value on innovation and the launch of BEAM marks a significant step forward, offering cutting-edge, dependable, and efficient solution for process environments. We believe that the BEAM will be a game-changer for the analysis of solid samples in process environments in the chemical, pharma, polymer, food and feed industry alike."
For more information about the BEAM, please visit www.bruker.com/BEAM
About Bruker Corporation
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com
Investor Contact:
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com
Media Contact:
Markus Ziegler
Sr. Director and Head of Group Marketing
Bruker Corporation
T: +49 172 3733531
E: pr@bruker.com